This meta-analysis was designed to investigate the effects of progressive RT on muscle strength and body composition in adult cancer patients. RT interventions resulted in a statistically significant improvement in muscle strength compared with controls. The increase of 14.6 kg for lower limb muscle strength (nine trials) and 6.9 kg for upper limb muscle strength (nine trials) was achieved during periods between 12 wk and 1 yr and compares well with reported improvements achieved in healthy elderly (61). The clinical significance of muscle strength for healthy adult and cancer survivors can be gauged by evaluating cross-sectional and longitudinal studies examining direct measurement of muscle strength in association with morbidity (3,29) and mortality (39,46). The Health, Aging, Body Composition Study study showed mortality to be associated with both lower limb and upper limb muscle strength, and this association remained significant even after adjustment for lean body mass (39). For quadriceps strength (per SD of 3.8 kg), the crude hazard ratio for men was 1.51 (95% CI = 1.128–1.79) and 1.65 (95% CI = 1.19–2.30) for women (29). Furthermore, the Aerobic Center Longitudinal Study noted that slightly higher levels of muscular strength (10.7 kg for leg press and 7.7 kg for bench press) were associated with 35% reduced cancer mortality in men, independent of body fat and cardiorespiratory fitness (46). Thus, the significant gain in muscle strength achieved in our review may increase life expectancy in cancer patients considerably. Although we found no significant differences between the RT group and the control group in V˙O2max (two trials), the improvement in the 12-min walk test with RT was statistically significant in two trials by Schwartz et al. (54,55). This may be in part due to an increase in muscle oxidative capacity and/or anaerobic muscle metabolism with RT (23,32).
In addition to the increase in muscle strength, RT also resulted in a significant overall increase in lean body mass by 1.07 kg (six trials) compared with controls. This is in accordance with a recent meta-analysis by Peterson et al. (43) reporting a weighted pooled estimate of mean lean body mass change by 1.1 kg (95% CI = 0.9–1.2 kg) with RT (mean duration: 20.5 ± 9.1 wk) in healthy aging adults. Thus, RT twice a week increases muscle mass by 1–2 kg per 6 months and could prevent age-associated loss of muscle mass in both healthy adults (38) and patients with chronic disease (62). In our meta-analysis, an RT intervention resulted in a significant lowering of percentage of body fat by 2.08% (eight trials) compared with the controls, but there was no significant difference between groups in body fat mass (−0.83 kg). The observed between-group effect sizes in body fat are similar to the effect sizes observed with aerobic training in adult patients after completion of main cancer treatment (−0.8%, −1.5 kg) (22). This result is not unimportant because already small reductions in body fat mass (1.5 kg) are associated with reductions in plasma lipid peroxidation (68). Oxidative stress may be related to cancer prognosis and is closely associated with mitochondrial dysfunction, cytokine dysregulation, and disruptions in muscle metabolism, and all of them have been postulated as mechanistic underpinnings of cancer-related fatigue (47). RT increases muscle protein synthesis (45), improves cytokine response (44), and diminishes atrophy (21). Furthermore, reduced body fat may also impact cancer prognosis as there is some evidence for a positive association between body fat and increased cancer-related mortality or recurrence (67).
On the basis of this meta-analysis, an RT intervention resulted in a significant reduction in FACT-Fatigue (four trials) compared with controls. The pooled results of the four studies examining the effect of RT on symptoms of fatigue showed a small effect; however, statistically significant improvements in symptoms of fatigue were reported in only two studies (56,57). One study used the Schwartz cancer fatigue scale and noted no improvements in fatigue with RT (73). The observed 1.9-point improvement in FACT-Fatigue with RT was lower than the 3.0-point threshold for minimal clinically important differences (9). Only four meta-analyses have concluded that physical activity had significant effects on reducing fatigue in cancer survivors (6,13,14,59). They reported at least small effects of physical activity. Cramp and Daniel (13) identified in their recent systematic review significant benefits of aerobic endurance training on cancer-related fatigue but RT failed to reach significance. Interestingly, Brown et al. (6) reported that RT had a positive, quadratic, and exercise intensity dose–response effect on cancer-related fatigue. Exercise reduced fatigue especially in programs that involved RT exercise among adult cancer survivors and that were of moderate to high intensity (60%–80% 1RM) (6). Thus, the intensity of exercise could play an important role in its effects. Fong et al. (22) reported significantly larger effects of aerobic plus RT than aerobic training alone on cancer-related fatigue that might indicate a potential benefit of higher intensity. In one study by Segal et al. (57), improvements in fatigue were associated with improvements in upper-body strength, but not hemoglobin. This suggests that RT may improve fatigue by improving neuromuscular efficiency and reducing muscular fatigue.
We observed a significant negative impact on upper limb muscle strength with increasing intensity. Metaregression revealed that low/moderate-intensity RT (≤75% 1RM) was associated with greater improvement than moderate/high-intensity RT (>75% 1RM). These data beg the question, how low can the RT intensity be and still produce a physiological adaptation and functional benefit? A recent study in healthy young adults showed that low-load high-volume leg RT to failure (30% 1RM) was more effective at increasing muscle protein synthesis than high-load low-volume RT to failure (90% 1RM) (7). Thus, RT-induced muscle protein synthesis may not necessarily be intensity dependent but may instead be determined by exercise volume. This would be important news for cancer patients who may be unable to sustain lifting weights at a relative high intensity due to sarcopenic comorbidities, such as connective tissue complications.
Although our metaregression suggests that moderate-intensity RT may be more effective than high-intensity for body fat loss, it is important to remember that the scientific evidence suggest only a modest effect of RT on body fatness and this may be influenced by whether the resistance exercise is accompanied by a concurrent reduction in energy intake (19). RT without energy restriction does not show clinically significant decreases in body weight; however, data show that RT may be an effective alternative to improve body composition in the short-term and long-term (1–2 kg loss of body fat with 1–2 kg increase in lean body mass) (18).
On the basis of our review, an RT intervention resulted in a significant improvement in FACT-Fatigue in studies reporting muscle strength or body composition as primary outcome measure. However, there was no evidence for associations between total exercise volume or mean intensity and beneficial effects on cancer-related fatigue. Although a recent meta-analysis conducted by Brown et al. demonstrated the superiority of higher intensity RT for fatigue reduction (6), no study has examined RT interventions greater than 80%1RM. It remains unknown whether more vigorous-intensity RT would provide greater or lesser reductions in cancer-related fatigue. For the current analysis, it is conceivable that the limited number of study groups and the overall lack of substantial variability in training regimens across intervention trials may have limited our analyses. Thus, further research is required to determine the optimal type and intensity of an exercise intervention on fatigue.
Limitations of the present review include the limited number of studies and the heterogeneity in study design. Heterogeneity may be explained by the range of different RT intervention used (and protocols used) across studies (64). Intervention differences included duration, frequency, intensity, and dose of exercise; diversity in the initial strength; and clinical status of participating individuals. The studies included had a broad array of populations: men and/or women; adults of any age; cancer survivors of any tumor type, tumor stage, and type of cancer treatment; and participants during treatment (radiotherapy, chemotherapy, and androgen deprivation therapy) or in long-term follow-up. Further, although the studies are expected to have internal validity, there may be limited generalizability because of differences between study participants and all cancer patients. Some studies did not provide information on the quality of the intervention such as randomization method, allocation concealment, and blinding of the study assignments to the persons performing the outcome measurements. However, the median quality score of 4 reflects high methodological quality of included trials.
Inspection of funnel plots suggests that publication bias cannot be excluded (see Figures, Supplemental Digital Content 3, http://links.lww.com/MSS/A279 and 4, http://links.lww.com/MSS/A280, which illustrate funnel plots showing study precision against the WMD effect estimate with 95% CI for lower- and upper-limb muscle strength, respectively). It appears that smaller studies with null results and larger SE may have been not published. The risk of publication bias might have been further increased by searching only three electronic databases and not contacting other experts for possible inclusion of more relevant studies as well as limiting this review to English-language publications.
The authors declare no funding and no conflict of interest.
The results of the present study do not constitute endorsement by the American College of Sports Medicine.
1. Abe T, DeHoyos DV, Pollock ML, Garzarella L. Time course of strength and muscle thickness changes following upper and lower body resistance training in men and women. Eur J Appl Physiol
. 2000; 81: 174–80.
2. Ahmed RL, Thomas W, Yee D, Schmitz KH. Randomized controlled trial of weight training and lymphedema in breast cancer
survivors. J Clin Oncol
. 2006; 24: 2765–72.
3. Atlantis E, Martin SA, Haren MT, Taylor AW, Wittert GA; Members of the Florey Adelaide Male Ageing Study. Inverse associations between muscle mass, strength, and the metabolic syndrome. Metabolism
. 2009; 58: 1013–22.
4. Battaglini C, Bottaro M, Dennehy C, et al. The effects of resistance training on muscle strength and fatigue in breast cancer
patients. Rev Bras Med Esporte
. 2007; 12: 139e–44e.
5. Battaglini C, Bottaro M, Dennehy C, et al. The effects of an individualized exercise
intervention on body composition in breast cancer
patients undergoing treatment. Sao Paulo Med J
. 2007; 125: 22–8.
6. Brown JC, Huedo-Medina TB, Pescatello LS, Pescatello SM, Ferrer RA, Johnson BT. Efficacy of exercise
interventions in modulating cancer
-related fatigue among adult cancer
survivors: a meta-analysis. Cancer Epidemiol Biomarkers Prev
. 2011; 20: 123–33.
7. Burd NA, West DW, Staples AW, et al. Low-load high volume resistance exercise
stimulates muscle protein synthesis more than high-load low volume resistance exercise
in young men. PLoS One
. 2010; 5: e12033.
8. Carrillo AE, Flynn MG, Pinkston C, et al. Impact of vitamin D supplementation during a resistance training intervention on body composition, muscle function
, and glucose tolerance in overweight and obese adults. Clin Nutr
. 2013; 32: 375–81.
9. Cella D, Eton DT, Lai JS, Peterman AH, Merkel DE. Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer
Therapy (FACT) anemia and fatigue scales. J Pain Symptom Manage
. 2002; 24: 547–61.
10. Cheema B, Gaul CA, Lane K, Fiatarone Singh MA. Progressive resistance training in breast cancer
: a sytematic review of clinical trials. Breast Cancer Res Treat
. 2008; 109: 9–26.
11. Cheville AL, Girardi J, Clark MM, et al. Therapeutic exercise
during outpatient radiation therapy for advanced cancer
. Am J Phys Med Rehabil
. 2010; 89: 611–19.
12. Courneya KS, Segal RJ, Mackey JR, et al. Effects of aerobic and resistance exercise
in breast cancer
patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial. J Clin Oncol
. 2007; 25: 4396–404.
13. Cramp F, Byron D. Exercise
for the management of cancer
-related fatigue in adults. Cochrane Database Syst Rev
. 2012; 11: CD006145.
14. Cramp F, Daniel J. Exercise
for the management for cancer
-related fatigue in adults. Cochrane Database Syst Rev
. 2008; 2: CD006145.
15. Cramp F, James A, Lambert J. The effects of resistance training on quality of life
: a systematic literature review and meta-analysis. Support Care Cancer
. 2010; 18: 1367–76.
16. De Backer IC, Schep G, Backx FJ, Vreugdenhil G, Kuipers H. Resistance training in cancer
survivors: a systematic review
. Int J Sports Med
. 2009; 30: 703–12.
17. Dimeo F. Effects of exercise
-related fatigue. Cancer
. 2001; 92: 1689–93.
18. Donnelly E, Jakicic M, Pronk NP. Is resistance exercise
effective for weight management? Evid Based Prev Med
. 2004; 1: 21–9.
19. Donnelly JE, Blair SN, Jakicic JM, Manore MM, Rankin JW, Smith BK; American College of Sports Medicine. Appropriate physical activity intervention strategies for weight loss and prevention of weight regain for adults. Med Sci Sports Exerc
. 2009; 41 (2): 459–71.
20. Doyle C, Kushi LH, Byers T, et al. Nutrition and physical activity during and after cancer
treatment: an American Cancer
Society guide for informed choices. CA Cancer J Clin
. 2006; 56: 323–53.
21. Fiatarone MA, Marks EC, Ryan ND, Meredith CN, Lipsitz LA, Evans WJ. High intensity strength training
in nonagenarians. Effects on skeletal muscle. JAMA
. 1990; 263: 3029–34
22. Fong DY, Ho JW, Hui BP, et al. Physical activity for cancer
survivors: meta-analysis of randomised controlled trials. BMJ
. 2012; 344: e70.
23. Frontera WR, Meredith CN, O’Reilly KP, Evans WJ. Strength training
and determinants of V˙O2max
in older men. J Appl Physiol
. 1990; 68: 329–33.
24. Galvao DA, Nosaka K, Taaffe DR, et al. Resistance training and reduction of treatment side effects in prostate cancer
patients. Med Sci Sports Exerc
. 2006; 38 (12): 2045–52.
25. Henwood TR, Taaffe DR. Improved physical performance in older adults undertaking a short-term programme of high-velocity resistance training. Gerontology
. 2005; 51: 108–15.
26. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ
. 2003; 327: 557–60.
27. Holick CN, Newcomb PA, Trentham-Dietz A, et al. Physical activity and survival after diagnosis of invasive breast cancer
. Cancer Epidemiol Biomarker Prev
. 2008; 17: 379–86.
28. Holmes MD, Chen WY, Feskanich D, Kroenke CH, Colditz GA. Physical activity and survival after breast cancer
. 2005; 293: 1479–86.
29. Jackson AW, Lee DC, Sui X, et al. Muscular strength is inversely related to prevalence and incidence of obesity in adult men. Obesity
. 2010; 18: 1988–95.
30. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials
. 1996; 17: 1–12.
31. Kraemer WJ, Adams K, Cafarelli E, et al.; American College of Sports Medicine. American College of Sports Medicine Position Stand. Progression models in resistance training for healthy adults. Med Sci Sports Exerc
. 2002; 34 (3): 364–80.
32. Larew K, Hunter GR, Larson-Meyer DE, Newcomer BR, McCarthy JP, Weinsier RL. Muscle metabolic function, exercise
performance, and weight gain. Med Sci Sports Exerc
. 2003; 35 (2): 230–6.
33. Marcell TJ. Sarcopenia: causes, consequences, and prevention. J Gerontol A Biol Sci Med Sci
. 2003; 58: M911–6.
34. McNeely ML, Parliament M, Courneya KS, et al. A pilot study of a randomized controlled trial to evaluate the effects of progressive resistance exercise
training on shoulder dysfunction caused by spinal accessory neurapraxia/neurectomy in head and neck cancer
survivors. Head Neck
. 2004; 26: 518–30.
35. McNeely ML, Parliament MB, Seikaly H, et al. Effect of exercise
on upper extremity pain and dysfunction in head and neck cancer
survivors. A randomized controlled trial. Cancer
. 2008; 113: 214–22.
36. Narici MV, Hoppeler H, Kayser B, et al. Human quadriceps cross-sectional area, torque and neural activation during 6 months strength training
. Acta Physiol Scand
. 1996; 157: 175–86.
37. National Comprehensive Cancer
Network. Clinical practice guidelines in oncology. Cancer
-related fatigue version 1 [Internet]. 2010 [cited 2010 August 10]. Available from: http://www.nccn.org
38. Nelson ME, Fiatarone MA, Morganti CM, Trice I, Greenberg RA, Evans WJ. Effects of high-intensity strength training
on multiple risk factors for osteoporotic fractures. JAMA
. 1994; 272: 1909–14.
39. Newman AB, Kupelian V, Visser M, et al. Strength but not muscle mass, is associated with mortality in the health aging and body composition study cohort. J Gerontol A Biol Sci Med Sci
. 2006; 61: 72–7.
40. Ohira T, Schmitz KH, Ahmed RL, Yee D. Effects of weight training on quality of life
in recent breast cancer
. 2006; 106: 2076–83.
41. Peddle-McIntyre CJ, Bell G, Fenton D, McCargar L, Courneya KS. Feasibility and preliminary efficacy of progressive resistance exercise
training in lung cancer
survivors. Lung Cancer
. 2012; 75: 126–32.
42. Peterson MD, Rhea MR, Sen A, Gordon PM. Resistance exercise
for muscular strength in older adults: a meta-analysis. Ageing Res Rev
. 2010; 9: 226–37.
43. Peterson MD, Sen A, Gordon PM. Influence of resistance exercise
on lean body mass in aging adults: a meta-analysis. Med Sci Sports Exerc
. 2011; 43 (2): 249–58.
44. Phillips MD, Flynn MG, McFarlin BK, Stewart LK, Timmerman KL. Resistance training at eight-repetition maximum reduces the inflammatory milieu in elderly women. Med Sci Sports Exerc
. 2010; 42 (2): 314–25.
45. Phillips SM, Tipton KD, Aarsland A, Wolf SE, Wolfe RR. Mixed muscle protein synthesis and breakdown after resistance exercise
in humans. Am J Physiol
. 1997; 273: E99–107.
46. Ruiz JR, Sui X, Lobelo F, et al. Muscular strength and adiposity as predictors of adulthood cancer
mortality in men. Cancer Epidemiol Biomarkers Prev
. 2009; 18: 1468–76.
47. Ryan JL, Carroll JK, Ryan EP, Mustian KM, Fiscella K, Morrow GR. Mechanisms of cancer
related fatigue. Oncologist
. 2007; 12: 22–34.
48. Schmidt T, Weisser B, Jonat W, Baumann FT, Mundhenke C. Gentle strength training
in rehabilitation of breast cancer
patients compared to conventional therapy. Anticancer Res
. 2012; 32: 3229–34.
49. Schmitz KH, Ahmed R, Hannan PJ, Yee D. Safety and efficacy of weight training in recent breast cancer
survivors to alter body composition, insulin, and insulin-like growth factor axis proteins. Cancer Epidemiol Biomarkers Prev
. 2005; 14: 1672–80.
50. Schmitz KH, Ahmed RL, Troxel AB, et al. Weight lifting for women at risk for breast cancer
-related lymphedema. JAMA
. 2010; 304: 2699–705.
51. Schmitz KH, Ahmed RL, Troxel AB, et al. Weight lifting in women with breast cancer
-related lymphedema. N Engl J Med
. 2009; 361: 664–73.
52. Schmitz KH, Courneya KS, Matthews C, et al.; American College of Sports Medicine. American College of Sports Medicine roundtable on exercise
guidelines for cancer
survivors. Med Sci Sports Exerc
. 2010; 42 (7): 1409–26.
53. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA
. 1995; 273: 408–12.
54. Schwartz AL, Winters-Stone K, Gallucci B. Exercise
effects on bone mineral density in women with breast cancer
receiving adjuvant chemotherapy. Oncol Nurs Forum
. 2007; 34: 627–33.
55. Schwartz AL, Winters-Stone KM. Effects of a 12-month randomized controlled trial of aerobic or resistance exercise
during and following cancer
treatment in women. Phys Sportsmed
. 2009; 37: 62–7
56. Segal RJ, Reid RD, Courneya KS, et al. Resistance exercise
in men receiving androgen deprivation therapy for prostate cancer
. J Clin Oncol
. 2003; 21: 1653–59.
57. Segal RJ, Reid RD, Courneya KS, et al. Randomized controlled trial of resistance or aerobic exercise
in men receiving radiation therapy for prostate cancer
. J Clin Oncol
. 2009; 27: 344–51.
58. Skipworth RJ, Stewart GD, Dejong CH, Preston T, Fearon KC. Pathophysiology of cancer
cachexia: much more than host-tumor interaction? Clin Nutr
. 2007; 26: 667–76.
59. Speck RM, Courneya KS, Mâsse LC, Duval S, Schmitz KH. An update of controlled physical activity trials in cancer
survivors: a systematic review
and meta-analysis. J Cancer Surviv
. 2010; 4: 87–100.
60. Speck RM, Gross CR, Hormes JM, et al. Changes in the body image and relationship scale following a one-year strength training
trial for breast cancer
survivors with or at risk for lymphedema. Breast Cancer Res Treat
. 2010; 121: 421–30.
61. Strasser B, Keinrad M, Haber P, Schobersberger W. Efficacy of systematic endurance and resistance training on muscle strength and endurance performance in elderly adults—a randomized controlled trial. Wien Klin Wochenschr
. 2009; 121: 757–64.
62. Strasser B, Leeb G, Strehblow C, Schobersberger W, Haber P, Cauza E. The effects of strength and endurance training in patients with rheumatoid arthritis. Clin Rheumatol
. 2011; 30: 623–32.
63. Strasser B, Siebert U, Schobersberger W. Resistance training in the treatment of the metabolic syndrome: a systematic review
and meta-analysis of the effect of resistance training on metabolic clustering in patients with abnormal glucose metabolism. Sports Med
. 2010; 40: 397–415.
64. Thompson SG. Why and how sources of heterogeneity should be investigated. In: Egger M, Smith GD, Altman DG, editors. Systematic Reviews in Health Care: Meta-Analysis in Context
. London: BMJ Publishing Group; 2001. p. 157–75.
65. Tisdale MJ. Cachexia in cancer
patients. Nat Rev Cancer
. 2002; 2: 862–71.
66. US Cancer
Statistics Working Group. United States Cancer Statistics: 2004 Incidence and Mortality
. Atlanta (GA): Department of Health and Human Services, Centers for Disease Control and Prevention, and National Cancer
Institute; 2007. p. 1–22.
67. Vance V, Mourtzakis M, McCargar L, Hanning R. Weight gain in breast cancer
survivors: prevalence, pattern and Health consequences. Obes Rev
. 2011; 12: 282–94.
68. Vincent HK, Bourguignon C, Vincent KR. Resistance training lowers exercise
-induced oxidative stress and homocysteine levels in overweight and obese older adults. Obesity
. 2006; 14: 1921–30.
69. Waltman NL, Twiss JJ, Ott CD, et al. The effect of weight training on bone mineral density and bone turnover in postmenopausal breast cancer
survivors with bone loss: a 24-month randomized controlled trial. Osteoporos Int
. 2010; 21: 1361–69.
70. Wernbom M, Augustsson J, Thomeé R. The influence of frequency, intensity, volume and mode of strength training
on whole muscle cross-sectional area in humans. Sports Med
. 2007; 37: 225–64.
71. Westcott W. Strength training
for frail older adults. J Active Aging
. 2009; 8: 52–9.
72. Williams MA, Haskell WL, Ades PA, et al.; American Heart Association Council on Clinical Cardiology; American Heart Association Council on Nutrition, Physical Activity, and Metabolism. Resistance exercise
in individuals with and without cardiovascular disease: 2007 update: a scientific statement from the American Heart Association Council on Clinical Cardiology and Council on Nutrition, Physical Activity, and Metabolism. Circulation
. 2007; 166: 572–84.
73. Winters-Stone KM, Dobek J, Bennett JA, Nail LM, Leo MC, Schwartz A. The effect of resistance training on muscle strength and physical function in older, postmenopausal breast cancer
survivors: a randomized controlled trial. J Cancer Surviv
. 2012; 6: 189–99.
74. Winters-Stone KM, Dobek J, Nail L, et al. Strength training
stops bone loss and builds muscle in postmenopausal breast cancer
survivors. A randomized, controlled trial. Breast Cancer Res Treat
. 2011; 127: 447–56.
75. Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer
Therapy measurement system. J Pain Symptom Manage
. 1997; 13: 63–74.
76. Yuen HK, Sword D. Home-based exercise
to alleviate fatigue and improve functional capacity among breast cancer
survivors. J Allied Health
. 2007; 36: e257–75.